Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today.
Net sales declined 12% year-over-year to $10.1 billion.
Net earnings decreased 48% to $1 billion while EPS fell 47% to $0.59. Adjusted earnings were down 23% to $1.8 billion while adjusted EPS dropped 22% to $1.03.
Abbott expects adjusted EPS from continuing operations to be $4.30-4.50 for the full year of 2023.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Shares of Mattel, Inc. (NASDAQ: MAT) were up slightly on Thursday. The stock has gained 20% year-to-date and 19% over the past three months. There is a level of optimism
Paychex Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is all set to publish operating results for the first three months of fiscal 2024. The company has
Darden Restaurants, Inc. (NYSE: DRI) reported first quarter 2024 earnings results today. Total sales increased 11.6% to $2.73 billion compared to the same period last year. Blended same-restaurant sales were